Opiant Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €34.86M +48.6% €2.58M -261.7% 7.4% +0.14 pp €1.65M -197.4% 4.7% +0.12 pp
    €23.46M -28.3% -€1.59M -116.1% -6.8% -0.37 pp -€1.69M -145.3% -7.2% -0.19 pp
    €32.73M +183.0% €9.92M -154.7% 30.3% +1.9 pp €3.74M -934.9% 11.4% +0.15 pp
    €11.57M -26.7% -€18.14M -422.1% -156.8% -1.9 pp -€447.71K -109.4% -3.9% -0.34 pp
    €15.79M +86.4% €5.63M -184.2% 35.7% +1.1 pp €4.76M -712.1% 30.1% +0.39 pp
    €8.47M +538.6% -€6.69M +11.0% -78.9% +3.8 pp -€777.12K -78.6% -9.2% +2.6 pp
    €1.33M +∞% -€6.03M -38.7% -454.1% -4.5 pp -€3.63M +321.7% -273.5% -2.7 pp
    €0.00 +NaN% -€9.83M +146.7% N/A -€860.65K +34.5% N/A
    €0.00 +NaN% -€3.99M -62.5% N/A -€639.76K -31.9% N/A
    €0.00 +NaN% -€10.63M +31.6% N/A -€938.91K -62.9% N/A
    €0.00 +NaN% -€8.08M +367.8% N/A -€2.53M +680.8% N/A
    €0.00 +NaN% -€1.73M -7,191.1% N/A -€324.10K -450,786.9% N/A
    €0.00 +NaN% €24.35K -258.7% N/A €71.91 -231.3% N/A
    €0.00 +NaN% -€15.34K -46.7% N/A -€54.79 -99.8% N/A
    €0.00 -€28.77K N/A -€28.72K N/A

    Notifications